|
Name |
Diaporthin
|
| Molecular Formula | C13H14O5 | |
| IUPAC Name* |
8-hydroxy-3-[(2S)-2-hydroxypropyl]-6-methoxyisochromen-1-one
|
|
| SMILES |
C[C@@H](CC1=CC2=CC(=CC(=C2C(=O)O1)O)OC)O
|
|
| InChI |
InChI=1S/C13H14O5/c1-7(14)3-10-5-8-4-9(17-2)6-11(15)12(8)13(16)18-10/h4-7,14-15H,3H2,1-2H3/t7-/m0/s1
|
|
| InChIKey |
ORLHWDAVUBPRKN-ZETCQYMHSA-N
|
|
| Synonyms |
Diaporthin; 10532-39-5; 348G93MX9Z; (S)-8-Hydroxy-3-(2-hydroxypropyl)-6-methoxy-1H-2-benzopyran-1-one; UNII-348G93MX9Z; CHEMBL4163739; DTXSID60909444; 8-hydroxy-3-[(2S)-2-hydroxypropyl]-6-methoxyisochromen-1-one; Isocoumarin, 8-hydroxy-3-(2-hydroxypropyl)-6-methoxy-, (+)-; 1H-2-Benzopyran-1-one, 8-hydroxy-3-(2-hydroxypropyl)-6-methoxy-, (S)-; Q27256349; 8-Hydroxy-3-(2-hydroxypropyl)-6-methoxy-1H-2-benzopyran-1-one; 8-HYDROXY-3-(2-HYDROXY-PROPYL)-6-METHOXY-ISOCHROMEN-1-ONE, (+)-; 8-HYDROXY-3-(2-HYDROXY-PROPYL)-6-METHOXY-ISOCHROMEN-1-ONE, (S)-; NCGC00384779-01!8-hydroxy-3-[(2S)-2-hydroxypropyl]-6-methoxyisochromen-1-one; 6512-79-4
|
|
| CAS | 10532-39-5 | |
| PubChem CID | 5323561 | |
| ChEMBL ID | CHEMBL4163739 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 250.25 | ALogp: | 2.1 |
| HBD: | 2 | HBA: | 5 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 76.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 18 | QED Weighted: | 0.87 |
| Caco-2 Permeability: | -4.865 | MDCK Permeability: | 0.00001570 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.859 |
| Human Intestinal Absorption (HIA): | 0.011 | 20% Bioavailability (F20%): | 0.012 |
| 30% Bioavailability (F30%): | 0.989 |
| Blood-Brain-Barrier Penetration (BBB): | 0.199 | Plasma Protein Binding (PPB): | 82.58% |
| Volume Distribution (VD): | 0.907 | Fu: | 17.70% |
| CYP1A2-inhibitor: | 0.971 | CYP1A2-substrate: | 0.913 |
| CYP2C19-inhibitor: | 0.347 | CYP2C19-substrate: | 0.413 |
| CYP2C9-inhibitor: | 0.481 | CYP2C9-substrate: | 0.937 |
| CYP2D6-inhibitor: | 0.181 | CYP2D6-substrate: | 0.828 |
| CYP3A4-inhibitor: | 0.111 | CYP3A4-substrate: | 0.192 |
| Clearance (CL): | 10.521 | Half-life (T1/2): | 0.619 |
| hERG Blockers: | 0.044 | Human Hepatotoxicity (H-HT): | 0.369 |
| Drug-inuced Liver Injury (DILI): | 0.614 | AMES Toxicity: | 0.092 |
| Rat Oral Acute Toxicity: | 0.048 | Maximum Recommended Daily Dose: | 0.645 |
| Skin Sensitization: | 0.649 | Carcinogencity: | 0.058 |
| Eye Corrosion: | 0.071 | Eye Irritation: | 0.8 |
| Respiratory Toxicity: | 0.104 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005211 | ![]() |
1.000 | D0DJ1B | ![]() |
0.297 | ||
| ENC002072 | ![]() |
0.772 | D06GCK | ![]() |
0.283 | ||
| ENC001634 | ![]() |
0.746 | D0Q1IT | ![]() |
0.280 | ||
| ENC004556 | ![]() |
0.727 | D0D1DI | ![]() |
0.280 | ||
| ENC001569 | ![]() |
0.727 | D04KJO | ![]() |
0.280 | ||
| ENC002113 | ![]() |
0.667 | D0T1LK | ![]() |
0.272 | ||
| ENC003380 | ![]() |
0.625 | D04UTT | ![]() |
0.270 | ||
| ENC003541 | ![]() |
0.617 | D07MGA | ![]() |
0.264 | ||
| ENC005162 | ![]() |
0.613 | D05CKR | ![]() |
0.260 | ||
| ENC005394 | ![]() |
0.585 | D04AIT | ![]() |
0.259 | ||